Flinders University

Activities

Activities per year 1974 2018 2019 2020 2021 2022 2023 2024 2031

• 940 Invited talk
• 495 Oral presentation
• 491 Other
• 146 Membership of committee
• 753 More
  • 144 Editorial work
  • 122 Participating in a conference, workshop, ...
  • 110 Organising a conference, workshop, ...
  • 96 Publication Peer-review
  • 96 Membership of network
  • 57 Examination
  • 46 Membership of board
  • 41 Visiting an external academic institution
  • 14 Consultancy
  • 14 Membership of council
  • 9 Converted from Research Output
  • 4 Hosting an academic visitor

Activities per year

Search results

• Flinders University 3-Minute Thesis (3MT) Contest (Judge)

  Williams, S. (Other)

  2017

  Activity: Other activity types › Other

• The role of expectations and dietary restraint in the effect of cue exposure on food intake

  Kemps, E. (Participant), Tiggemann, M. (Participant), Hollitt, S. (Participant), Prichard, I. (Participant), Polivy, J. (Participant) & Herman, C. P. (Participant)

  2016

  Activity: Other activity types › Other

• Centre for Global Food and Resources Research Seminar (Co-ordinator)

  Zuo, A. (Other)

  2016 → 2022

  Activity: Other activity types › Other

• Unhealthy eating behaviour: Understanding and modifying the influence of automatic and controlled processes

  Kakoschke, N. (Participant), Kemps, E. (Participant) & Tiggemann, M. (Participant)

  2016

  Activity: Other activity types › Other

• Tuning into Kids Emotional Growth Psychological Clinic Course

  Matthews, S. (Participant)

  24 Jun 2016

  Activity: Other activity types › Other

• Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar. Déry JP, Mahaffey KW, Tricoci P, White HD, Podder M, Westerhout CM, Moliterno DJ, Harrington RA, Chen E, Strony J, Van de Werf F, Ziada KM, Held C, Aylward PE, Armstrong PW, Rao SV. Catheter Cardiovasc Interv. 2016 Aug;88(2):163-73. doi: 10.1002/ccd.26335. Epub 2015 Dec 23. PMID: 26698636 Clinical Trial.

  Morton, E. (Other)

  2016

  Activity: Other activity types › Other

• Effect of approach bias modification in the domain of healthy eating behaviour

  Kakoschke, N. (Participant), Kemps, E. (Participant) & Tiggemann, M. (Participant)

  2016

  Activity: Other activity types › Other

• Chloro-chek Chloridometer Key Operator Training Course

  Matthews, S. (Participant)

  2 Nov 2016

  Activity: Other activity types › Other

• Undergraduate Summer Research Scholarship

  Watson, M. (Participant)

  2016 → …

  Activity: Other activity types › Other

• Comparing alternative definitions of Fried's Frailty Criteria using self-reported survey data: the Australian DYNOPTA study (Poster)

  Dent, E. (Participant)

  2016

  Activity: Other activity types › Other

• Use of thienopyridine prior to presentation with non-ST-segment elevation acute coronary syndrome and association with safety and efficacy of vorapaxar: insights from the TRACER trial. Harskamp RE, Clare RM, Ambrosio G, Held C, Lokhnygina Y, Moliterno DJ, White HD, Aylward PE, Armstrong PW, Mahaffey KW, Harrington RA, Van de Werf F, Wallentin L, Strony J, Tricoci P. Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):155-163. doi: 10.1177/2048872616633880. Epub 2016 Sep 20. PMID: 26895973 Clinical Trial.

  Morton, E. (Other)

  2016

  Activity: Other activity types › Other

• STATA software training (AARES SA branch)

  Zuo, A. (Other)

  2016

  Activity: Other activity types › Other

• Research leader ‘Oceanic Cultures & Connections’ cluster, University of Tasmania

  Edmonds, P. (Other)

  2016 → …

  Activity: Other activity types › Other

• World Poetry Day - Interview by Dugald Saunders, ABC Radio

  Parisot, E. (Participant)

  21 Mar 2016

  Activity: Other activity types › Other

• Robyn Archer- The (Other) Great American Songbook

  Morley, M. (Participant) & Archer, R. (Participant)

  2016

  Activity: Other activity types › Other

• Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibition. Ungar L, Rodriguez F, Mahaffey KW. Coron Artery Dis. 2016 Nov;27(7):604-15. doi: 10.1097/MCA.0000000000000409. PMID: 27398626 Review.

  Morton, E. (Other)

  2016

  Activity: Other activity types › Other

• GoldFFX Basic User Training and Chemical Manifold Material Safety Data Sheet (MSDS) and Document Search Training

  Matthews, S. (Participant)

  4 Oct 2016

  Activity: Other activity types › Other

• Co-director, University Research Theme ‘Creativity, Culture, and Society’, University of Tasmania

  Edmonds, P. (Other)

  2016 → 2017

  Activity: Other activity types › Other

• Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Armaganijan LV, Alexander KP, Huang Z, Tricoci P, Held C, Van de Werf F, Armstrong PW, Aylward PE, White HD, Moliterno DJ, Wallentin L, Chen E, Harrington RA, Strony J, Mahaffey KW, Lopes RD. Am Heart J. 2016 Aug;178:176-84. doi: 10.1016/j.ahj.2016.05.012. Epub 2016 Jun 9. PMID: 27502866

  Morton, E. (Other)

  2016

  Activity: Other activity types › Other

• Research leader ‘Experimental Histories’ cluster, University of Tasmania

  Edmonds, P. (Other)

  2016 → …

  Activity: Other activity types › Other

• Understanding and modifying the influence of cognitive processes on unhealthy eating behaviour

  Kakoschke, N. (Participant), Kemps, E. (Participant) & Tiggemann, M. (Participant)

  2016

  Activity: Other activity types › Other

• Testing the online delivery of cognitive defusion and guided imagery techniques to reduce naturally occurring food cravings and consumption

  Schumacher, S. (Participant), Kemps, E. (Participant) & Tiggemann, M. (Participant)

  2016

  Activity: Other activity types › Other

• Robyn Archer- Dancing on the Volcano

  Morley, M. (Other), Archer, R. (Participant), Barber, D. (Other) & Butumlis, G. (Other)

  2016

  Activity: Other activity types › Other

• Vorapaxar monotherapy for secondary stroke prevention: A call for randomized trial. Serebruany VL, Kim MH, Hanley DF. Int J Stroke. 2016 Aug;11(6):614-7. doi: 10.1177/1747493016632253. Epub 2016 Feb 9. PMID: 26860124 Review.

  Morton, E. (Other)

  2016

  Activity: Other activity types › Other

• Pancreatic Safety of Sitagliptin in the TECOS Study. Buse JB, Bethel MA, Green JB, Stevens SR, Lokhnygina Y, Aschner P, Grado CR, Tankova T, Wainstein J, Josse R, Lachin JM, Engel SS, Patel K, Peterson ED, Holman RR; TECOS Study Group. Diabetes Care. 2017 Feb;40(2):164-170. doi: 10.2337/dc15-2780. Epub 2016 Sep 14. PMID: 27630212. Clinical Trial.

  Morton, E. (Other)

  2016

  Activity: Other activity types › Other

• Student Wellbeing and Prevention of Violence

  Skrzypiec, G. (Participant)

  Jun 2015

  Activity: Other activity types › Other

• The History of Suicide - Interview by Kim Kleidon, ABC Radio

  Parisot, E. (Participant)

  5 May 2015

  Activity: Other activity types › Other

• Should the Dose of Antiplatelet Drugs Be Adjusted for Body Weight? The Example of Vorapaxar. Serebruany VL, Fortmann SD, Kim MH. Cardiology. 2016;133(2):69-72. doi: 10.1159/000440798. Epub 2015 Oct 22. PMID: 26488178 Clinical Trial.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Vorapaxar in the secondary prevention of atherothrombosis. Tantry US, Liu F, Chen G, Gurbel PA. Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1293-305. doi: 10.1586/14779072.2015.1109447. Epub 2015 Nov 12. PMID: 26559689 Review.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis. Diehl P, Bode C, Duerschmied D. Ther Clin Risk Manag. 2015 Aug 3;11:1133-8. doi: 10.2147/TCRM.S55469. eCollection 2015. PMID: 26346960. Review.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• The FDA review on data quality and conduct in vorapaxar trials: Much better than in PLATO, but still not perfect. Serebruany VL, Choi SY, Kim MH. Int J Cardiol. 2016 Feb 15;205:13-16. doi: 10.1016/j.ijcard.2015.12.001. Epub 2015 Dec 3. PMID: 26709134

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Royal Children's Hospital Internal Auditor Training

  Matthews, S. (Participant)

  1 Oct 2015

  Activity: Other activity types › Other

• Social security for migrant workers in Nanjing and Sichuan

  Tan, Y. (Other), Zuo, A. (Other) & Watson, A. (Other)

  2015

  Activity: Other activity types › Other

• Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery. van Diepen S, Tricoci P, Podder M, Westerhout CM, Aylward PE, Held C, Van de Werf F, Strony J, Wallentin L, Moliterno DJ, White HD, Mahaffey KW, Harrington RA, Armstrong PW. J Am Heart Assoc. 2015 Dec 15;4(12):e002546. doi: 10.1161/JAHA.115.002546. PMID: 26672080 Clinical Trial.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial). Cornel JH, Tricoci P, Lokhnygina Y, Moliterno DJ, Wallentin L, Armstrong PW, Aylward PE, Clare RM, Chen E, Leonardi S, Van de Werf F, White HD, Held C, Strony J, Mahaffey KW, Harrington RA. Am J Cardiol. 2015 May 15;115(10):1325-32. doi: 10.1016/j.amjcard.2015.02.043. Epub 2015 Feb 18. PMID: 25776457 Clinical Trial.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Deputy Chair of the Humanities ERA Excellence in Research Australia panel, University of Tasmania

  Edmonds, P. (Other)

  2015

  Activity: Other activity types › Other

• Plasma PAFAH/PLA2G7 Genetic Variability, Cardiovascular Disease, and Clinical Trials. Karabina S, Ninio E. Enzymes. 2015;38:145-55. doi: 10.1016/bs.enz.2015.09.002. Epub 2015 Oct 17. PMID: 26612651

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Mapping and valuing ecosystem services in South Africa, Tanzania and Zambia: Final report to UNCCD

  Willemen, L. (Participant), Crossman, N. (Participant), Egoh, B. (Participant), Kalaba, F. K. (Participant), Mbilinyi, B. (Participant) & de Groot, R. (Participant)

  2015

  Activity: Other activity types › Other

• Vorapaxar for secondary stroke prevention: perspectives and obstacles. Serebruany VL, Kim MH, Fortmann SD, Hanley DF. Expert Rev Neurother. 2015;15(12):1377-82. doi: 10.1586/14737175.2015.1111761. Epub 2015 Nov 13. PMID: 26566105

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Harmonising Age Pathology Parameters in Kids (HAPPI Kids)

  Matthews, S. (Participant)

  31 Dec 2015

  Activity: Other activity types › Other

• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. PMID: 26052984 Clinical Trial.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A2 (Lp-PLA2) as a biomarker or risk factor for cardiovascular diseases. Hassan M. Glob Cardiol Sci Pract. 2015 Jan 26;2015:6. doi: 10.5339/gcsp.2015.6. eCollection 2015. PMID: 25830150.

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• To the root of political suicide, figuratively speaking - In Daily

  Parisot, E. (Participant)

  6 Mar 2015

  Activity: Other activity types › Other

• Redesigning TRACER trial after TRITON. Serebruany VL. Int J Cardiol. 2015 Oct 15;197:44-7. doi: 10.1016/j.ijcard.2015.06.020. Epub 2015 Jun 18. PMID: 26126053

  Morton, E. (Other)

  2015

  Activity: Other activity types › Other

• Development of an online screening tool to identify the needs of new clients and refer them to service

  Lawn, S. (Participant), Morello, A. (Participant), Oster, C. (Participant), Redpath, P. (Participant), Venning, A. (Participant), Cromarty, P. (Participant) & Drummond, A. (Participant)

  2015

  Activity: Other activity types › Other

• Story board and E-Collage for the Dignity in Mental Health Project, World Federation for Mental Health (WFMH).

  Lawn, S. (Participant)

  2015

  Activity: Other activity types › Other

• Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9. PMID: 24402559 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Darapladib for preventing ischemic events in stable coronary heart disease. STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30. PMID: 24678955 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER. White HD, Huang Z, Tricoci P, Van de Werf F, Wallentin L, Lokhnygina Y, Moliterno DJ, Aylward PE, Mahaffey KW, Armstrong PW. J Am Heart Assoc. 2014 Jul 10;3(4):e001032. doi: 10.1161/JAHA.114.001032. PMID: 25012288. Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other

• Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. Held C, Tricoci P, Huang Z, Van de Werf F, White HD, Armstrong PW, Ambrosio G, Aylward PE, Moliterno DJ, Wallentin L, Chen E, Erkan A, Jiang L, Strony J, Harrington RA, Mahaffey KW. Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):246-56. doi: 10.1177/2048872614527838. Epub 2014 Mar 13. PMID: 24627331 Clinical Trial.

  Morton, E. (Other)

  2014

  Activity: Other activity types › Other